The global US Remote Patient Monitoring Market, valued at US$14.15 billion in 2024, is forecasted to grow at a robust CAGR of 12.8%, reaching ...

Nick Jonas writes about his diabetes journey, "The Last Five Years," fatherhood and more in this exclusive essay.

Four years into the mutually negotiated 10-year contract between Diabeter, a type 1 diabetes mellitus care-integrated ...

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

The Smart Medical Implants Market was valued at US$ 5.7 Bn in 2022 and is projected to grow at a CAGR of 18.1% from 2023 to 2031, reaching more than US$ 24.8 Bn by the end of 2031. The increasing ...

Dexcom stock plunged to a four-month low Monday after the FDA issued a warning letter tied to inspections of two facilities ...

US stocks plunge, with S&P 500 and Nasdaq posting the largest one-day loss since 2022 after Trump declined to rule out ...

Bengaluru: Medical device maker Dexcom said it has received a warning letter from the U.S. Food and Drug Administration following inspections of its two key manufacturing facilities, sending its ...

(Reuters) -Medical device maker Dexcom (NASDAQ:DXCM) said it has received a warning letter from the U.S. Food and Drug Administration following inspections of its two key manufacturing facilities ...

A stock is considered to be oversold if the RSI reading falls below 30. In trading on Friday, shares of DexCom Inc (Symbol: DXCM) entered into oversold territory, hitting an RSI reading of 29.6 ...

DexCom received a warning letter from the Food and Drug Administration following inspections of its San Diego and Mesa, Ariz. facilities and is working on a written response. The diabetes devices ...